Financial overview

BerGenBio financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre
Pre

Description

BerGenBio is a Norwegian oncology company. The company conducts research and development of inhibitory drugs for the treatment of aggressive cancers. The company has developed a number of products whose composition intends to block the protein AXL, a protein positively related to the spread of cancer cells. The company was founded in 2007 and is headquartered in Bergen.

Biotechnology